Calcineurin controls drug tolerance, hyphal growth, and virulence in Candida dubliniensis

Eukaryotic Cell

Volumn 10, Issue 6, 2011, Pages 803-819

  Chen, Ying Lien ^a   Brand, Alexandra ^b   Morrison, Emma L ^b   Silao, Fitz Gerald S ^c   Bigol, Ursela G ^d   Malbas Jr , Fedelino F ^e   Nett, Jeniel E ^f,g,h   Andes, David R ^f,g,h   Solis, Norma V ⁱ   Filler, Scott G ^i,j   Averette, Anna ^a   Heitman, Joseph ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c Dr Jose G Tamayo Medical University   (Philippines)

^d Environment and Biotechnology Division   (Philippines)

^e Department of Health   (Philippines)

^f University of Medicine   (United States)

^g Medical Microbiology and Immunology   (United States)

^h UNIVERSITY OF WISCONSIN MADISON   (United States)

ⁱ HARBOR UCLA MEDICAL CENTER   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CALCINEURIN; CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE;

ANIMAL; ANTIFUNGAL RESISTANCE; ARTICLE; BACTERIAL COUNT; BIOFILM; CANDIDA; CANDIDEMIA; DENTURE; DRUG EFFECT; FUNGAL EYE INFECTION; FUNGUS HYPHAE; GENE SILENCING; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; MOTH; MOUSE; PATHOGENICITY; RAT; SPRAGUE DAWLEY RAT; THRUSH; VIRULENCE;

ANIMALS; ANTIFUNGAL AGENTS; BIOFILMS; CALCINEURIN; CANDIDA; CANDIDEMIA; CANDIDIASIS, ORAL; COLONY COUNT, MICROBIAL; DENTURES; DRUG RESISTANCE, FUNGAL; ECHINOCANDINS; EYE INFECTIONS, FUNGAL; FLUCONAZOLE; GENE KNOCKDOWN TECHNIQUES; HUMANS; HYPHAE; MALE; MICE; MICE, INBRED ICR; MICROBIAL VIABILITY; MOTHS; RATS; RATS, SPRAGUE-DAWLEY; VIRULENCE;

ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; FILOBASIDIELLA NEOFORMANS; FUNGI; MURINAE; RATTUS;

EID: 79957942182     PISSN: 15359778     EISSN: None     Source Type: Journal    
DOI: 10.1128/EC.00310-10     Document Type: Article

References (91)

1. Allen, E. A., H. C. Hoch, J. R. Stavely, and J. R. Steadman. 1991. Uniformity among races of Uromyces appendiculatus in response to topographical signaling for appressorium formation. Phytopathology 81:883-887.
2. Andes, D., et al. 2004. Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. Infect. Immun. 72:6023-6031.
3. Aramburu, J., J. Heitman, and G. R. Crabtree. 2004. Calcineurin: a central controller of signalling in eukaryotes. EMBO Rep. 5:343-348.
4. Bader, T., B. Bodendorfer, K. Schroppel, and J. Morschhauser. 2003. Calcineurin is essential for virulence in Candida albicans. Infect. Immun. 71: 5344-5354.
5. Bader, T., et al. 2006. Role of calcineurin in stress resistance, morphogenesis, and virulence of a Candida albicans wild-type strain. Infect. Immun. 74:4366-4369.
6. Badiee, P., A. Alborzi, M. A. Davarpanah, and E. Shakiba. 2010. Distributions and antifungal susceptibility of Candida species from mucosal sites in HIV positive patients. Arch. Iran. Med. 13:282-287.
7. Blankenship, J. R., and J. Heitman. 2005. Calcineurin is required for Candida albicans to survive calcium stress in serum. Infect. Immun. 73:5767-5774.
8. Blankenship, J. R., et al. 2003. Calcineurin is essential for Candida albicans survival in serum and virulence. Eukaryot. Cell 2:422-430.
9. Brand, A., and N. A. Gow. 2009. Mechanisms of hypha orientation of fungi. Curr. Opin. Microbiol. 12:350-357.
10. Brand, A., K. Lee, V. Veses, and N. A. Gow. 2009. Calcium homeostasis is required for contact-dependent helical and sinusoidal tip growth in Candida albicans hyphae. Mol. Microbiol. 71:1155-1164.
11. Brand, A., et al. 2007. Hyphal orientation of Candida albicans is regulated by a calcium-dependent mechanism. Curr. Biol. 17:347-352.
12. Brand, A., et al. 2008. An internal polarity landmark is important for externally induced hyphal behaviors in Candida albicans. Eukaryot. Cell 7:712-720.
13. Brandt, M. E., et al. 2000. Candida dubliniensis fungemia: the first four cases in North America. Emerg. Infect. Dis. 6:46-49.
14. Braun, B. R., and A. D. Johnson. 1997. Control of filament formation in Candida albicans by the transcriptional repressor TUP1. Science 277:105-109.
15. Calderone, R. A., and W. A. Fonzi. 2001. Virulence factors of Candida albicans. Trends Microbiol. 9:327-335.
16. Chen, W. L., Y. Y. Tsai, J. M. Lin, and C. C. Chiang. 2009. Unilateral Candida parapsilosis interface keratitis after laser in situ keratomileusis: case report and review of the literature. Cornea 28:105-107.
17. Chen, Y. L., S. Kauffman, and T. B. Reynolds. 2008. Candida albicans uses multiple mechanisms to acquire the essential metabolite inositol during infection. Infect. Immun. 76:2793-2801.
18. Chen, Y. L., L. Kozubowski, M. E. Cardenas, and J. Heitman. 2010. On the roles of calcineurin in fungal growth and pathogenesis. Curr. Fungal Infect. Rep. 4:244-255.
19. Chen, Y. L., et al. 2010. Phosphatidylserine synthase and phosphatidylserine decarboxylase are essential for cell wall integrity and virulence in Candida albicans. Mol. Microbiol. 75:1112-1132.
20. Choi, J., Y. Kim, S. Kim, J. Park, and Y. H. Lee. 2009. MoCRZ1, a gene encoding a calcineurin-responsive transcription factor, regulates fungal growth and pathogenicity of Magnaporthe oryzae. Fungal Genet. Biol. 46: 243-254.
21. Choi, J. H., Y. Kim, and Y. H. Lee. 2009. Functional analysis of MCNA, a gene encoding a catalytic subunit of calcineurin, in the rice blast fungus Magnaporthe oryzae. J. Microbiol. Biotechnol. 19:11-16.
22. Chunchanur, S. K., et al. 2009. Detection and antifungal susceptibility testing of oral Candida dubliniensis from human immunodeficiency virus-infected patients. Indian J. Pathol. Microbiol. 52:501-504.
23. Coco, B. J., et al. 2008. Mixed Candida albicans and Candida glabrata populations associated with the pathogenesis of denture stomatitis. Oral Microbiol. Immunol. 23:377-383.
24. Cramer, R. A., Jr., et al. 2008. Calcineurin target CrzA regulates conidial germination, hyphal growth, and pathogenesis of Aspergillus fumigatus. Eukaryot. Cell 7:1085-1097.
25. Crombie, T., N. A. Gow, and G. W. Gooday. 1990. Influence of applied electrical fields on yeast and hyphal growth of Candida albicans. J. Gen. Microbiol. 136:311-317.
26. Cruz, M. C., et al. 2002. Calcineurin is essential for survival during membrane stress in Candida albicans. EMBO J. 21:546-559.
27. Davis, D., R. B. Wilson, and A. P. Mitchell. 2000. RIM101-dependent andindependent pathways govern pH responses in Candida albicans. Mol. Cell. Biol. 20:971-978.
28. Del Poeta, M., M. C. Cruz, M. E. Cardenas, J. R. Perfect, and J. Heitman. 2000. Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans. Antimicrob. Agents Chemother. 44:739-746.
29. Egan, J. D., M. D. Garcia-Pedrajas, D. L. Andrews, and S. E. Gold. 2009. Calcineurin is an antagonist to PKA protein phosphorylation required for postmating filamentation and virulence, while PP2A is required for viability in Ustilago maydis. Mol. Plant Microbe Interact. 22:1293-1301.
30. Elorza, M. V., H. Rico, and R. Sentandreu. 1983. Calcofluor white alters the assembly of chitin fibrils in Saccharomyces cerevisiae and Candida albicans cells. J. Gen. Microbiol. 129:1577-1582.
31. Enjalbert, B., et al. 2009. Genome-wide gene expression profiling and a forward genetic screen show that differential expression of the sodium ion transporter Ena21 contributes to the differential tolerance of Candida albicans and Candida dubliniensis to osmotic stress. Mol. Microbiol. 72:216-228.
32. Fonzi, W. A., and M. Y. Irwin. 1993. Isogenic strain construction and gene mapping in Candida albicans. Genetics 134:717-728.
33. Fortwendel, J. R., et al. 2009. Differential effects of inhibiting chitin and 1,3--D-glucan synthesis in ras and calcineurin mutants of Aspergillus fumigatus. Antimicrob. Agents Chemother. 53:476-482.
34. Gasparoto, T. H., et al. 2009. Isolation of Candida dubliniensis from denture wearers. J. Med. Microbiol. 58:959-962.
35. Gilfillan, G. D., et al. 1998. Candida dubliniensis: phylogeny and putative virulence factors. Microbiology 144:829-838.
36. Gillum, A. M., E. Y. Tsay, and D. R. Kirsch. 1984. Isolation of the Candida albicans gene for orotidine-5-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol. Gen. Genet. 198:179-182.
37. Greenblatt, M. B., A. Aliprantis, B. Hu, and L. H. Glimcher. 2010. Calcineurin regulates innate antifungal immunity in neutrophils. J. Exp. Med. 207: 923-931.
38. Hemady, R. K. 1995. Microbial keratitis in patients infected with the human immunodeficiency virus. Ophthalmology 102:1026-1030.
39. Hemady, R. K., N. Griffin, and B. Aristimuno. 1993. Recurrent corneal infections in a patient with the acquired immunodeficiency syndrome. Cornea 12:266-269.
40. Jabra-Rizk, M. A., et al. 2005. Prevalence of Candida dubliniensis fungemia at a large teaching hospital. Clin. Infect. Dis. 41:1064-1067.
41. Jackson, A. P., et al. 2009. Comparative genomics of the fungal pathogens Candida dubliniensis and Candida albicans. Genome Res. 19:2231-2244.
42. Karababa, M., et al. 2006. CRZ1, a target of the calcineurin pathway in Candida albicans. Mol. Microbiol. 59:1429-1451.
43. Kofteridis, D. P., R. E. Lewis, and D. P. Kontoyiannis. 2010. Caspofunginnon- susceptible Candida isolates in cancer patients. J. Antimicrob. Chemother. 65:293-295.
44. Kojima, K., Y. S. Bahn, and J. Heitman. 2006. Calcineurin, Mpk1 and Hog1 MAPK pathways independently control fludioxonil antifungal sensitivity in Cryptococcus neoformans. Microbiology 152:591-604.
45. Kontoyiannis, D. P., et al. 2008. Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis. Antimicrob. Agents Chemother. 52:735-738.
46. LaFayette, S. L., et al. 2010. PKC signaling regulates drug resistance of the fungal pathogen Candida albicans via circuitry comprised of Mkc1, calcineurin, and Hsp90. PLoS Pathog. 6:e1001069.
47. Lo, H. J., et al. 1997. Nonfilamentous C. albicans mutants are avirulent. Cell 90:939-949.
48. Marcos-Arias, C., et al. 2009. Isolation of Candida dubliniensis in denture stomatitis. Arch. Oral Biol. 54:127-131.
49. McManus, B. A., et al. 2009. Genetic differences between avian and human isolates of Candida dubliniensis. Emerg. Infect. Dis. 15:1467-1470.
50. Miyazaki, T., et al. 2010. Roles of calcineurin and Crz1 in antifungal susceptibility and virulence of Candida glabrata. Antimicrob. Agents Chemother. 54:1639-1643.
51. Monge, R. A., E. Roman, C. Nombela, and J. Pla. 2006. The MAP kinase signal transduction network in Candida albicans. Microbiology 152:905-912.
52. Moran, G. P., et al. 1997. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob. Agents Chemother. 41:617-623.
53. Mylonakis, E., et al. 2005. Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis. Infect. Immun. 73:3842-3850.
54. Nett, J. E., K. Marchillo, C. A. Spiegel, and D. R. Andes. 2010. Development and validation of an in vivo Candida albicans biofilm denture model. Infect. Immun. 78:3650-3659.
55. Noble, S. M., S. French, L. A. Kohn, V. Chen, and A. D. Johnson. 2010. Systematic screens of a Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenicity. Nat. Genet. 42:590-598.
56. Nunn, M. A., S. M. Schaefer, M. A. Petrou, and J. R. Brown. 2007. Environmental source of Candida dubliniensis. Emerg. Infect. Dis. 13:747-750.
57. O'Connor, L., N. Caplice, D. C. Coleman, D. J. Sullivan, and G. P. Moran. 2010. Differential filamentation of Candida albicans and C. dubliniensis is governed by nutrient regulation of UME6 expression. Eukaryot. Cell 9:1383-1397.
58. Odds, F. C., A. J. Brown, and N. A. Gow. 2003. Antifungal agents: mechanisms of action. Trends Microbiol. 11:272-279.
59. Odom, A., et al. 1997. Calcineurin is required for virulence of Cryptococcus neoformans. EMBO J. 16:2576-2589.
60. Onyewu, C., N. A. Afshari, and J. Heitman. 2006. Calcineurin promotes infection of the cornea by Candida albicans and can be targeted to enhance fluconazole therapy. Antimicrob. Agents Chemother. 50:3963-3965.
61. Onyewu, C., J. R. Blankenship, M. Del Poeta, and J. Heitman. 2003. Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei. Antimicrob. Agents Chemother. 47:956-964.
62. Onyewu, C., F. L. Wormley, Jr., J. R. Perfect, and J. Heitman. 2004. The calcineurin target, Crz1, functions in azole tolerance but is not required for virulence of Candida albicans. Infect. Immun. 72:7330-7333.
63. Park, H., et al. 2005. Role of the fungal Ras-protein kinase A pathway in governing epithelial cell interactions during oropharyngeal candidiasis. Cell. Microbiol. 7:499-510.
64. Perea, S., et al. 2002. Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis. Antimicrob. Agents Chemother. 46:1695-1703.
65. Perfect, J. R., N. Ketabchi, G. M. Cox, C. W. Ingram, and C. L. Beiser. 1993. Karyotyping of Cryptococcus neoformans as an epidemiological tool. J. Clin. Microbiol. 31:3305-3309.
66. Reuss, O., A. Vik, R. Kolter, and J. Morschhauser. 2004. The SAT1 flipper, an optimized tool for gene disruption in Candida albicans. Gene 341:119-127.
67. Roncero, C., and A. Duran. 1985. Effect of calcofluor white and congo red on fungal cell wall morphogenesis: in vivo activation of chitin polymerization. J. Bacteriol. 163:1180-1185.
68. Sanglard, D., F. Ischer, O. Marchetti, J. Entenza, and J. Bille. 2003. Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence. Mol. Microbiol. 48:959-976.
69. Santos, M., and I. F. de Larrinoa. 2005. Functional characterization of the Candida albicans CRZ1 gene encoding a calcineurin-regulated transcription factor. Curr. Genet. 48:88-100.
70. Singh, S. D., et al. 2009. Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin. PLoS Pathog. 5:e1000532.
71. Spiering, M. J., et al. 2010. Comparative transcript profiling of Candida albicans and Candida dubliniensis identifies SFL2, a C. albicans gene required for virulence in a reconstituted epithelial infection model. Eukaryot. Cell 9:251-265.
72. Stathopoulos, A. M., and M. S. Cyert. 1997. Calcineurin acts through the CRZ1/TCN1-encoded transcription factor to regulate gene expression in yeast. Genes Dev. 11:3432-3444.
73. Steinbach, W. J., et al. 2006. Calcineurin controls growth, morphology, and pathogenicity in Aspergillus fumigatus. Eukaryot. Cell 5:1091-1103.
74. Steinbach, W. J., et al. 2007. Calcineurin inhibition or mutation enhances cell wall inhibitors against Aspergillus fumigatus. Antimicrob. Agents Chemother. 51:2979-2981.
75. Steinbach, W. J., J. L. Reedy, R. A. Cramer, Jr., J. R. Perfect, and J. Heitman. 2007. Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections. Nat. Rev. Microbiol. 5:418-430.
76. Stie, J., and D. Fox. 2008. Calcineurin regulation in fungi and beyond. Eukaryot. Cell 7:177-186.
77. Stokes, C., et al. 2007. Lower filamentation rates of Candida dubliniensis contribute to its lower virulence in comparison with Candida albicans. Fungal Genet. Biol. 44:920-931.
78. Sullivan, D. J., G. P. Moran, and D. C. Coleman. 2005. Candida dubliniensis: ten years on. FEMS Microbiol. Lett. 253:9-17.
79. Sullivan, D. J., et al. 2004. Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans. FEMS Yeast Res. 4:369-376.
80. Sullivan, D. J., T. J. Westerneng, K. A. Haynes, D. E. Bennett, and D. C. Coleman. 1995. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIVinfected individuals. Microbiology 141:1507-1521.
81. Tappeiner, C., D. Goldblum, S. Zimmerli, C. Fux, and B. E. Frueh. 2009. Donor-to-host transmission of Candida glabrata to both recipients of corneal transplants from the same donor. Cornea 28:228-230.
82. Thompson, G. R., III, et al. 2010. Oropharyngeal candidiasis in the era of antiretroviral therapy. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 109:488-495.
83. Tukmachev, V. A., L. V. Nedospasova, B. Zaslavskii, and S. V. Rogozhin. 1979. Effect of sodium dodecyl sulfate on biological membranes. Biofizika 24:55-60. (In Russian.)
84. Uppuluri, P., J. Nett, J. Heitman, and D. Andes. 2008. Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms. Antimicrob. Agents Chemother. 52:1127-1132.
85. Vilela, M. M., et al. 2002. Pathogenicity and virulence of Candida dubliniensis: comparison with C. albicans. Med. Mycol. 40:249-257.
86. Walker, L. A., N. A. Gow, and C. A. Munro. 2010. Fungal echinocandin resistance. Fungal Genet. Biol. 47:117-126.
87. Walker, L. A., et al. 2008. Stimulation of chitin synthesis rescues Candida albicans from echinocandins. PLoS Pathog. 4:e1000040.
88. Watts, H. J., A. A. Very, T. H. Perera, J. M. Davies, and N. A. Gow. 1998. Thigmotropism and stretch-activated channels in the pathogenic fungus Candida albicans. Microbiology 144:689-695.
89. Wu, T. G., K. R. Wilhelmus, and B. M. Mitchell. 2003. Experimental keratomycosis in a mouse model. Invest. Ophthalmol. Vis. Sci. 44:210-216.
90. Yadan, J. C., M. Gonneau, P. Sarthou, and F. Le Goffic. 1984. Sensitivity to nikkomycin Z in Candida albicans: role of peptide permeases. J. Bacteriol. 160:884-888.
91. Yoshida, T., T. Toda, and M. Yanagida. 1994. A calcineurin-like gene ppb1 in fission yeast: mutant defects in cytokinesis, cell polarity, mating and spindle pole body positioning. J. Cell Sci. 107:1725-1735.